Cited by 32Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesOvarian function and disordersSexual Differentiation and Disorders

Anti-Müllerian hormone levels in patients with Turner syndrome: relation to karyotype, spontaneous puberty, and replacement therapy

Hamza, Rasha T., Mira, Marwa F., Hamed, Amira I., Ezzat, Treiz, Sallam, Mahmoud T.·2018·American Journal of Medical Genetics Part A

Abstract

Most girls with Turner syndrome (TS) suffer from incomplete sexual development, premature ovarian failure, and infertility due to abnormal ovarian folliculogenesis. Serum anti-Müllerian hormone (AMH) levels reflect the ovarian reserve in females, even in childhood. Thus, we aimed to assess serum AMH levels in girls with TS and its relation to karyotype, spontaneous puberty, and growth hormone (GH) therapy. Fifty TS were compared to 50 age- and sex-matched controls. All subjects were subjected to history, anthropometric assessment, Tanner pubertal staging and measurement of serum follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and AMH. Karyotype results were obtained from patients' records. Serum AMH was measurable in 12 TS patients (24%). The lowest frequency of measurable AMH was in patients with a karyotype of 45,X. The measurable AMH was associated with spontaneous breast development (p = .003) and spontaneous menarche (p = .001). AMH correlated negatively with FSH (r = -.846, p = .000) and LH (r = -.83, p = .034). GH therapy increased the odds of having measurable AMH in TS girls (p = .002). In conclusion, AMH was associated with karyotype, spontaneous pubertal development, LH, and FSH in TS girls and may serve as a useful marker of ovarian function and ongoing follicular development in prepuberty.

Integrity signals

Registry

Crossref · 10.1002/ajmg.a.40473

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hamza, R. T., Mira, M. F., Hamed, A. I., Ezzat, T., & Sallam, M. T.
Affiliations
  • Ain Shams University (EG)
  • Cairo University (EG)
  • National Research Centre (EG)
Corresponding author
Hamza, Rasha T.
Venue
American Journal of Medical Genetics Part A
Publisher
Wiley
Published
2018-08-08
Volume
176
Issue
9
Pages
1929-1934
ISSN
  • 1552-4825 (ISSN-L)
  • 1552-4833
OpenAlex
W2886732399
Cited by
32
References
16
Citations by year
2026: 3 · 2025: 2 · 2024: 8 · 2023: 6 · 2022: 5 · 2021: 3 · 2020: 5
FWCI
1.23
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Medical Genetics Part A (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
Keywords
Turner syndrome, anti-Müllerian hormone, ovarian reserve, premature ovarian failure, spontaneous puberty, growth hormone therapy, karyotype, 45,X, follicle-stimulating hormone, luteinizing hormone, estradiol, prepubertal girls, ovarian function
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Menarche, Phenotype, Puberty, ROC Curve, Turner Syndrome, Biomarkers, Case-Control Studies, Hormone Replacement Therapy, Anti-Mullerian Hormone, Young Adult, Genetic Association Studies, Karyotype

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review